Get the Stockscreener App
9.53
3.70%
+0.34
After Hours:
9.53
Adverum Biotechnologies Inc Stock (ADVM) Forecast
The Adverum Biotechnologies Inc (ADVM) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $3.246, representing a -65.94% decrease from the current price of $9.53. The highest analyst price target is $4.6023, and the lowest is $1.8898.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ADVM Price Target
Average 8.3479
(-12.40% Downside)
Is Adverum Biotechnologies Inc (ADVM) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 45.07 | Neutral |
| STOCH(9,6) | 10.99 | Buy |
| STOCHRSI(14) | 13.45 | Buy |
| MACD(12,26) | 0.3493 | Sell |
| ADX(14) | 33.65 | Sell |
| William %R | -78.03 | Neutral |
| CCI(14) | -148.35 | Sell |
Buy: 2
Sell: 3
Neutral: 2
Summary: Sell
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
10.61
Sell
|
10.40
Sell
|
| MA20 |
11.52
Sell
|
10.52
Sell
|
| MA50 |
7.525
Buy
|
8.3569
Buy
|
| MA100 |
4.3174
Buy
|
5.8806
Buy
|
| MA200 |
2.8665
Buy
|
3.8556
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, ADVM could be considered a Potential Buy, with 17 technical analysis indicators signaling 8 Buy signals, 7 signaling Sell signals and 2 Neutral signals. This might be a good time to open fresh positions on ADVM, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 45.07 indicates that ADVM is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 10.99 indicates that ADVM is oversold. This indicates that ADVM price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 13.45 indicates that ADVM is oversold. This suggests that ADVM price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 33.65 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -148.35 indicates that ADVM is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term ADVM price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Adverum Biotechnologies Inc financial reports and earnings history, Adverum Biotechnologies Inc (ADVM) stock could reach $2.6195 by 2030, $1.946 by 2040 and $4.9112 by 2050. See the projected annual prices until 2050 of the Adverum Biotechnologies Inc stock below:
- Adverum Biotechnologies Inc (ADVM) is expected to reach an average price of $0.3581 in 2035, with a high prediction of $0.402 and a low estimate of $0.112. This indicates an $-96.24% rise from the last recorded price of $9.53.
- Adverum Biotechnologies Inc (ADVM) stock is projected to chart a bullish course in 2040, with an average price target of $1.8418, representing an $-80.67% surge from its current level. The forecast ranges from a conservative $1.8744 to a sky-high $1.946.
- Our analysts predict Adverum Biotechnologies Inc (ADVM) to jump -66.88% by 2045, soaring from $2.941 to an average price of $3.156, potentially reaching $3.087. While $2.941 is the low estimate, the potential upside is significant.
- Adverum Biotechnologies Inc (ADVM) stock is expected to climb by 2050, reaching an average of $4.9375, a $-48.19% jump from its current level. However, a wide range of estimates exists, with high and low targets of $4.9112 and $4.9537, respectively, highlighting the market's uncertainty.
Adverum Biotechnologies Inc Stock (ADVM) Year by Year Forecast
Adverum Biotechnologies Inc Stock (ADVM) Price Forecast for 2024
Our forecast for ADVM stock price in 2024 now indicates an average price target of $7.3329 with a high forecast of $14.16 and a low forecast of $0.5085. The average prediction reflects an decrease of -23.05% from the last recorded price of $9.53.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $4.2885 | $1.8898 | $4.6023 | -55.00% |
| June, 2024 | $7.7235 | $3.8148 | $7.8585 | -18.96% |
| July, 2024 | $9.9048 | $7.6198 | $10.25 | +3.93% |
| August, 2024 | $11.31 | $9.7703 | $14.16 | +18.68% |
| September, 2024 | $8.081 | $8.021 | $11.74 | -15.20% |
| October, 2024 | $3.311 | $2.8485 | $10.74 | -65.26% |
| November, 2024 | $4.821 | $2.8248 | $5.031 | -49.41% |
| December, 2024 | $7.2223 | $4.4635 | $7.2723 | -24.22% |
Adverum Biotechnologies Inc Stock (ADVM) Price Forecast for 2025
Adverum Biotechnologies Inc Stock (ADVM) is expected to reach an average price of $15.28 in 2025, with a high prediction of $25.10 and a low estimate of $5.461. This indicates an +60.35% rise from the last recorded price of $9.53.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $8.4223 | $6.8185 | $9.6073 | -11.62% |
| February, 2025 | $9.5348 | $8.2398 | $10.40 | +0.05% |
| March, 2025 | $8.9535 | $7.7521 | $10.15 | -6.05% |
| April, 2025 | $9.7385 | $8.6285 | $14.81 | +2.19% |
| May, 2025 | $7.6385 | $5.461 | $10.24 | -19.85% |
| June, 2025 | $9.9148 | $6.3198 | $12.48 | +4.04% |
| July, 2025 | $18.64 | $9.221 | $21.87 | +95.59% |
| August, 2025 | $22.65 | $14.65 | $23.25 | +137.72% |
| September, 2025 | $16.44 | $15.45 | $25.10 | +72.47% |
| October, 2025 | $11.46 | $9.921 | $17.41 | +20.26% |
| November, 2025 | $9.806 | $9.196 | $11.97 | +2.90% |
| December, 2025 | $8.0673 | $8.0573 | $11.52 | -15.35% |
Adverum Biotechnologies Inc Stock (ADVM) Price Forecast for 2026
The predicted value for Adverum Biotechnologies Inc (ADVM) in 2026 is set at an average of $6.861. Estimates vary from a peak of $13.12 to a trough of $0.5985, indicating an -28.01% surge from the present price of $9.53.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $9.1623 | $8.1535 | $10.83 | -3.86% |
| February, 2026 | $12.38 | $9.0785 | $12.85 | +29.88% |
| March, 2026 | $10.59 | $9.8823 | $12.99 | +11.11% |
| April, 2026 | $11.72 | $8.871 | $13.12 | +23.02% |
| May, 2026 | $11.21 | $10.19 | $12.95 | +17.61% |
| June, 2026 | $8.3298 | $7.6198 | $12.24 | -12.59% |
| July, 2026 | $7.2748 | $6.9948 | $9.2585 | -23.66% |
| August, 2026 | $1.916 | $1.866 | $8.7573 | -79.90% |
| September, 2026 | $2.141 | $1.7923 | $2.2598 | -77.53% |
| October, 2026 | $2.036 | $1.806 | $2.3373 | -78.64% |
| November, 2026 | $0.8673 | $0.751 | $2.1623 | -90.90% |
| December, 2026 | $0.8923 | $0.5985 | $1.1173 | -90.64% |
Adverum Biotechnologies Inc Stock (ADVM) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Adverum Biotechnologies Inc (ADVM) is $0.5562, with a high forecast of $1.1098 and a low forecast of $0.00274. This indicates an -94.16% decrease from the last price of $9.53.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $0.7473 | $0.6648 | $1.0373 | -92.16% |
| February, 2027 | $0.5513 | $0.5223 | $1.1098 | -94.22% |
| March, 2027 | $0.5735 | $0.4985 | $0.9848 | -93.98% |
| April, 2027 | $0.4285 | $0.3298 | $0.6198 | -95.50% |
| May, 2027 | $0.2398 | $0.2098 | $0.7173 | -97.48% |
| June, 2027 | $0.1348 | $0.1348 | $0.3885 | -98.59% |
| July, 2027 | $0.0302 | $0.00274 | $0.161 | -99.68% |
| August, 2027 | $0.071 | $0.024 | $0.2685 | -99.25% |
| September, 2027 | $0.134 | $0.00274 | $0.1373 | -98.59% |
| October, 2027 | $0.2912 | $0.1877 | $0.2852 | -96.94% |
| November, 2027 | $0.0877 | $0.1677 | $0.2327 | -99.08% |
| December, 2027 | $0.5273 | $0.00524 | $0.6973 | -94.47% |
Adverum Biotechnologies Inc Stock (ADVM) Price Forecast for 2028
In 2028, Adverum Biotechnologies Inc (ADVM) is projected to reach an average price of $0.3309, with a high projection of $0.6535 and a low estimate of $0.00826. This indicates an -96.53% fall from the last price of $9.53.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $0.1785 | $0.166 | $0.6535 | -98.13% |
| February, 2028 | $0.0735 | $0.0165 | $0.2148 | -99.23% |
| March, 2028 | $0.0665 | $0.0202 | $0.1598 | -99.30% |
| April, 2028 | $0.1515 | $0.1352 | $0.1115 | -98.41% |
| May, 2028 | $0.3153 | $0.2802 | $0.2652 | -96.69% |
| June, 2028 | $0.3902 | $0.338 | $0.3098 | -95.91% |
| July, 2028 | $0.2347 | $0.294 | $0.344 | -97.54% |
| August, 2028 | $0.283 | $0.2565 | $0.2341 | -97.03% |
| September, 2028 | $0.089 | $0.1353 | $0.1892 | -99.07% |
| October, 2028 | $0.00774 | $0.1414 | $0.1136 | -99.92% |
| November, 2028 | $0.0127 | $0.0115 | $0.1785 | -99.87% |
| December, 2028 | $0.4123 | $0.00826 | $0.4423 | -95.67% |
Adverum Biotechnologies Inc Stock (ADVM) Price Forecast for 2029
The 2029 price forecast for Adverum Biotechnologies Inc Stock (ADVM) is $0.8783 on average, with a high prediction of $1.588 and a low estimate of $0.1686. This represents an -90.78% decrease from the previous price of $9.53.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.9335 | $0.3185 | $1.0235 | -90.20% |
| February, 2029 | $1.4385 | $0.9223 | $1.586 | -84.91% |
| March, 2029 | $0.8835 | $0.7935 | $1.5198 | -90.73% |
| April, 2029 | $0.9948 | $0.6749 | $1.1523 | -89.56% |
| May, 2029 | $0.3001 | $0.2006 | $1.081 | -96.85% |
| June, 2029 | $0.3013 | $0.1955 | $0.5148 | -96.84% |
| July, 2029 | $0.2961 | $0.1711 | $0.436 | -96.89% |
| August, 2029 | $1.6955 | $0.1686 | $1.588 | -82.21% |
| September, 2029 | $1.5855 | $1.5005 | $1.5155 | -83.36% |
| October, 2029 | $1.033 | $1.213 | $1.543 | -89.16% |
| November, 2029 | $0.577 | $0.363 | $0.767 | -93.95% |
| December, 2029 | $1.4145 | $0.312 | $1.5495 | -85.16% |
Adverum Biotechnologies Inc Stock (ADVM) Price Forecast for 2030
Adverum Biotechnologies Inc Stock (ADVM) is expected to reach an average price of $6.742 in 2030, with a high forecast of $12.80 and a low forecast of $0.682. This signifies an -29.25% decrease from the last price of $9.53.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1.9895 | $0.992 | $2.6195 | -79.12% |
| February, 2030 | $6.6495 | $1.677 | $6.9395 | -30.23% |
| March, 2030 | $7.6695 | $6.172 | $8.0195 | -19.52% |
| April, 2030 | $6.857 | $6.672 | $11.93 | -28.05% |
| May, 2030 | $5.902 | $5.842 | $9.4995 | -38.07% |
| June, 2030 | $1.157 | $0.682 | $8.5645 | -87.86% |
| July, 2030 | $3.1109 | $0.6895 | $3.3045 | -67.36% |
| August, 2030 | $5.1245 | $2.347 | $5.1745 | -46.23% |
| September, 2030 | $6.602 | $4.727 | $7.5345 | -30.72% |
| October, 2030 | $6.937 | $6.1795 | $8.3395 | -27.21% |
| November, 2030 | $6.937 | $5.7293 | $8.122 | -27.21% |
| December, 2030 | $5.4895 | $3.5695 | $12.80 | -42.40% |
1.51%
Cap:
|
Volume (24h):